Mechanisms Underlying the Development of T-Cell Tolerance Following Interruption of Signalling at the CD28/B7 and CD40/gp39 Interface

Similar Items

• Prevention of T-Cell Activation by rhCTLA4-Ig and Anti-CD40L Monoclonal Antibody Results in Indefinite Islet Allograft Survival
  od: Rasteilini, C., i dr.
  Izdano: (1999)
• Combined Blockade of CD28/B7 and CD40/CD40L Costimulatory Pathways Prevents the Onset of Chronic Rejection
  od: Subbotin, V., i dr.
  Izdano: (1998)
• An essential role for gp39, the ligand for CD40, in thymic selection
  Izdano: (1995)
• In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39
  Izdano: (1993)
• Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.
  od: Durie, F H, i dr.
  Izdano: (1994)